Search research articles
Contact Us
Filters
Showing results (31-40 of 38) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 38 results.
Hypertension (Dallas, Tex. : 1979)
|
December 26, 2007
Telmisartan inhibits CD4-positive lymphocyte migration independent of the angiotensin type 1 receptor via peroxisome proliferator-activated receptor-gamma
Daniel Walcher, Katharina Hess, Philipp Heinz, et al.
Diabetes & Vascular Disease Research
|
May 13, 2010
Rapid effect of single-dose rosiglitazone treatment on endothelial function in healthy men with normal glucose tolerance: data from a randomised, placebo-controlled, double-blind study
Thomas Walcher, Daniel Walcher, Jürgen Hetzel, et al.
Diabetes
|
September 28, 2004
Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products
Nikolaus Marx, Daniel Walcher, Nina Ivanova, et al.
Diabetes Research and Clinical Practice
|
June 12, 2010
Effect of high-dose valsartan on inflammatory and lipid parameters in patients with Type 2 diabetes and hypertension
Ulrich Kintscher, Nikolaus Marx, Peter Martus, et al.
BMC Gastroenterology
|
October 10, 2009
Vitamin C supplement use may protect against gallstones: an observational study on a randomly selected population
Thomas Walcher, Mark M Haenle, Martina Kron, et al.
Scientific Reports
|
November 11, 2018
Amyloid precursor protein-fragments-containing inclusions in cardiomyocytes with basophilic degeneration and its association with cerebral amyloid angiopathy and myocardial fibrosis
Lara Maria Krämer, Johannes Brettschneider, Jochen K Lennerz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 18, 2006
Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: data from a randomized placebo-controlled trial
Franz Meisner, Daniel Walcher, Florence Gizard, et al.
The Journal of Clinical Investigation
|
December 4, 2012
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling
Katrin Faber, Lars Bullinger, Christine Ragu, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 38) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 38 results.
Hypertension (Dallas, Tex. : 1979)
|
December 26, 2007
Telmisartan inhibits CD4-positive lymphocyte migration independent of the angiotensin type 1 receptor via peroxisome proliferator-activated receptor-gamma
Daniel Walcher, Katharina Hess, Philipp Heinz, et al.
Diabetes & Vascular Disease Research
|
May 13, 2010
Rapid effect of single-dose rosiglitazone treatment on endothelial function in healthy men with normal glucose tolerance: data from a randomised, placebo-controlled, double-blind study
Thomas Walcher, Daniel Walcher, Jürgen Hetzel, et al.
Diabetes
|
September 28, 2004
Thiazolidinediones reduce endothelial expression of receptors for advanced glycation end products
Nikolaus Marx, Daniel Walcher, Nina Ivanova, et al.
Diabetes Research and Clinical Practice
|
June 12, 2010
Effect of high-dose valsartan on inflammatory and lipid parameters in patients with Type 2 diabetes and hypertension
Ulrich Kintscher, Nikolaus Marx, Peter Martus, et al.
BMC Gastroenterology
|
October 10, 2009
Vitamin C supplement use may protect against gallstones: an observational study on a randomly selected population
Thomas Walcher, Mark M Haenle, Martina Kron, et al.
Scientific Reports
|
November 11, 2018
Amyloid precursor protein-fragments-containing inclusions in cardiomyocytes with basophilic degeneration and its association with cerebral amyloid angiopathy and myocardial fibrosis
Lara Maria Krämer, Johannes Brettschneider, Jochen K Lennerz, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 18, 2006
Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: data from a randomized placebo-controlled trial
Franz Meisner, Daniel Walcher, Florence Gizard, et al.
The Journal of Clinical Investigation
|
December 4, 2012
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPARγ signaling
Katrin Faber, Lars Bullinger, Christine Ragu, et al.
Page
of 4